148 related articles for article (PubMed ID: 11259613)
41. DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes.
Menendez JA; Vellon L; Lupu R
Int J Mol Med; 2006 Dec; 18(6):1081-7. PubMed ID: 17089011
[TBL] [Abstract][Full Text] [Related]
42. Enhanced coexpression of YB-1 and DNA topoisomerase II alpha genes in human colorectal carcinomas.
Shibao K; Takano H; Nakayama Y; Okazaki K; Nagata N; Izumi H; Uchiumi T; Kuwano M; Kohno K; Itoh H
Int J Cancer; 1999 Dec; 83(6):732-7. PubMed ID: 10597187
[TBL] [Abstract][Full Text] [Related]
43. Sp1 mediates cell proliferation-dependent regulation of rat DNA topoisomerase IIalpha gene promoter.
Yoon JH; Kim JK; Rha GB; Oh M; Park SH; Seong RH; Hong SH; Park SD
Biochem J; 1999 Dec; 344 Pt 2(Pt 2):367-74. PubMed ID: 10567217
[TBL] [Abstract][Full Text] [Related]
44. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth.
Hashimoto S; Chatterjee S; Ranjit GB; Bao C; Ford J; Ganapathi R; Berger SJ; Berger NA
Oncol Res; 1995; 7(7-8):407-16. PubMed ID: 8747604
[TBL] [Abstract][Full Text] [Related]
45. CCAAT binding factor (CBF) binding mediates cell cycle activation of topoisomerase IIalpha. Conventional CBF activation domains are not required.
Hu Q; Bhattacharya C; Maity SN
J Biol Chem; 2002 Oct; 277(40):37191-200. PubMed ID: 12149265
[TBL] [Abstract][Full Text] [Related]
46. Evidence for repressional role of an inverted CCAAT box in cell cycle-dependent transcription of the human DNA topoisomerase IIalpha gene.
Falck J; Jensen PB; Sehested M
J Biol Chem; 1999 Jun; 274(26):18753-8. PubMed ID: 10373491
[TBL] [Abstract][Full Text] [Related]
47. Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors.
Magan N; Szremska AP; Isaacs RJ; Stowell KM
Biochem J; 2003 Sep; 374(Pt 3):723-9. PubMed ID: 12769819
[TBL] [Abstract][Full Text] [Related]
48. Mutations at arg486 and glu571 in human topoisomerase IIalpha confer resistance to amsacrine: relevance for antitumor drug resistance in human cells.
Patel S; Keller BA; Fisher LM
Mol Pharmacol; 2000 Apr; 57(4):784-91. PubMed ID: 10727526
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of transcription factor-DNA complexes and gene expression by a microgonotropen.
White CM; Satz AL; Bruice TC; Beerman TA
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10590-5. PubMed ID: 11535831
[TBL] [Abstract][Full Text] [Related]
50. Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay.
Withoff S; Smit EF; Meersma GJ; van den Berg A; Timmer-Bosscha H; Kok K; Postmus PE; Mulder NH; de Vries EG; Buys CH
Lab Invest; 1994 Jul; 71(1):61-6. PubMed ID: 8041119
[TBL] [Abstract][Full Text] [Related]
51. Inhibiting transcription factor/DNA complexes using fluorescent microgonotropens (FMGTs).
White CM; Satz AL; Gawron LS; Bruice TC; Beerman TA
Biochim Biophys Acta; 2002 Feb; 1574(1):100-8. PubMed ID: 11955618
[TBL] [Abstract][Full Text] [Related]
52. Reduced level of ATF is correlated with transcriptional repression of DNA topoisomerase II alpha gene during TPA-induced differentiation of HL-60 cells.
Lim K; Lee JI; Yun KA; Son MY; Park JI; Yoon WH; Hwang BD
Biochem Mol Biol Int; 1998 Sep; 46(1):35-42. PubMed ID: 9784837
[TBL] [Abstract][Full Text] [Related]
53. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
Morgan SE; Cadena RS; Raimondi SC; Beck WT
Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
[TBL] [Abstract][Full Text] [Related]
54. Characterization of DNA topoisomerase II alpha/beta heterodimers in HeLa cells.
Gromova I; Biersack H; Jensen S; Nielsen OF; Westergaard O; Andersen AH
Biochemistry; 1998 Nov; 37(47):16645-52. PubMed ID: 9843432
[TBL] [Abstract][Full Text] [Related]
55. Formation of topoisomerase II alpha complexes with nascent DNA is related to VM-26-induced cytotoxicity.
Qiu J; Catapano CV; Fernandes DJ
Biochemistry; 1996 Dec; 35(50):16354-60. PubMed ID: 8973211
[TBL] [Abstract][Full Text] [Related]
56. p53 regulates the minimal promoter of the human topoisomerase IIalpha gene.
Sandri MI; Isaacs RJ; Ongkeko WM; Harris AL; Hickson ID; Broggini M; Vikhanskaya F
Nucleic Acids Res; 1996 Nov; 24(22):4464-70. PubMed ID: 8948636
[TBL] [Abstract][Full Text] [Related]
57. Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization.
Wessel I; Jensen PB; Falck J; Mirski SE; Cole SP; Sehested M
Cancer Res; 1997 Oct; 57(20):4451-4. PubMed ID: 9377550
[TBL] [Abstract][Full Text] [Related]
58. Atypical multidrug resistance may be associated with catalytically active mutants of human DNA topoisomerase II alpha.
Okada Y; Tosaka A; Nimura Y; Kikuchi A; Yoshida S; Suzuki M
Gene; 2001 Jul; 272(1-2):141-8. PubMed ID: 11470519
[TBL] [Abstract][Full Text] [Related]
59. Regulation by ionizing radiation of CDC2, cyclin A, cyclin B, thymidine kinase, topoisomerase IIalpha, and RAD51 expression in normal human diploid fibroblasts is dependent on p53/p21Waf1.
de Toledo SM; Azzam EI; Keng P; Laffrenier S; Little JB
Cell Growth Differ; 1998 Nov; 9(11):887-96. PubMed ID: 9831241
[TBL] [Abstract][Full Text] [Related]
60. Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells.
Chen HH; Chang HH; Chang JY; Tang YC; Cheng YC; Lin LM; Cheng SY; Huang CH; Sun MW; Chen CT; Kuo CC
Free Radic Biol Med; 2017 Dec; 113():505-518. PubMed ID: 29080842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
